You just read:

Oncolytics Biotech® Inc. and Adlai Nortye Enter into USD $86.6 Million Regional Licensing Agreement for REOLYSIN®

News provided by

Oncolytics Biotech Inc.

Nov 16, 2017, 17:00 ET